Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
ANRO
Stock Latest News
The Fly
Alto Neuroscience highlights study results guiding ALTO-207 development
7d ago
ANRO
Premium
Ratings
Optimistic Buy Rating for Alto Neuroscience Amid Promising ALTO-203 Developments and Strategic Opportunities
10d ago
ANRO
Premium
Ratings
Promising Phase 2 Results for ALTO-203 in Treating Anhedonia-MDD Justify Buy Rating
11d ago
ANRO
Premium
The Fly
Alto Neuroscience identifies biomarker, reports ALTO-203 pharmacodynamic results
11d ago
ANRO
Premium
Company Announcements
Alto Neuroscience Reports Positive Phase 2 Trial Results
11d ago
8K
ANRO
Premium
Ratings
Promising Future for Alto Neuroscience: Strategic Acquisition and Strong Financial Position Drive Buy Rating
26d ago
ANRO
Premium
Ratings
Buy Rating for Alto Neuroscience Driven by Strategic Acquisitions and Promising Pipeline Developments
1M ago
ANRO
Premium
Ratings
Alto Neuroscience’s Strategic Acquisition and Promising Pipeline Boost Buy Rating
1M ago
ANRO
Premium
Ratings
Strategic Acquisition and Promising Clinical Developments Drive Buy Rating for Alto Neuroscience, Inc.
1M ago
ANRO
Premium
Company Announcements
Alto Neuroscience Acquires Assets from Chase Therapeutics
1M ago
8K
ANRO
Premium
The Fly
Alto Neuroscience acquires dopamine agonist combination candidate
1M ago
ANRO
Premium
Ratings
Alto Neuroscience, Inc.: Promising Clinical Trials and Strong Financial Position Justify Buy Rating
2M ago
ANRO
Premium
Company Announcements
Alto Neuroscience Advances Precision Psychiatry Pipeline
2M ago
ANRO
Premium
Ratings
Alto Neuroscience, Inc.: Buy Rating Affirmed on Strong Financial Outlook and Promising Clinical Trials
2M ago
ANRO
Premium
Ratings
Promising Future for Alto Neuroscience: Strong Pipeline and Financial Stability Drive Buy Rating
2M ago
ANRO
Premium
Company Announcements
Alto Neuroscience Approves Key Proposals at Annual Meeting
2M ago
8K
ANRO
Premium
Ratings
Optimistic Outlook on Alto Neuroscience: Advancements in Precision Neuropsychiatry and Biomarker-Driven Treatments
2M ago
ANRO
Premium
Ratings
Innovative Biomarker-Driven Strategy and Promising Pipeline Support Buy Rating for Alto Neuroscience
2M ago
ANRO
Premium
The Fly
Alto Neuroscience presents new data at Society of Biological Psychiatry meeting
2M ago
ANRO
Premium
The Fly
Alto Neuroscience initiated with a Buy at H.C. Wainwright
3M ago
ANRO
Premium
Ratings
Buy Rating Reaffirmed for Alto Neuroscience, Inc. Amid Promising Pipeline and Upcoming Data Readouts
3M ago
ANRO
Premium
Ratings
Promising Clinical Trials and Strong Financials Justify Buy Rating for Alto Neuroscience, Inc.
4M ago
ANRO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.